Understanding patient perspectives on communication about the cost of cancer care: A review of the literature

Journal of Oncology Practice

Volumn 6, Issue 4, 2010, Pages 188-192

  Hofstatter, Erin W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CARE; CANCER PATIENT; CANCER THERAPY; DOCTOR PATIENT RELATION; HEALTH CARE COST; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL LITERATURE; NEOPLASM; PATIENT ATTITUDE; PATIENT CARE; PATIENT DECISION MAKING; PATIENT SATISFACTION; PRACTICE GUIDELINE; REVIEW;

EID: 77958123055     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.777002     Document Type: Review

References (32)

1. Meropol NJ, Schrag D, Smith TJ, et al: American Society of Clinical Oncology guidance statement: The cost of cancer care. J Clin Oncol 27:3868-3874, 2009
2. Kim P: Cost of cancer care: The patient perspective. J Clin Oncol 25:228-232, 2007 (Pubitemid 350003039)
3. McFarlane J, Riggins J, Smith TJ: SPIKE$: A six-step protocol for delivering bad news about the cost of medical care. J Clin Oncol 26:4200-4204, 2008
4. Bodurtha JN: "What's this going to cost, Doctor?" Acad Med 71:937-938, 1996
5. Jefford M, Mileshkin L, Schofield P, et al: Discussing expensive anticancer drugs. J Clin Oncol 27:476-477, 2008
6. Keehan S, Sisko A, Truffer C, et al: Health spending projections through 2017: The baby-boom generation is coming to Medicare. Health Aff (Millwood) 27: w145-w155, 2008
7. National Cancer Institute: Cancer trends progress report 2009/2010: Costs of cancer care. http://progressreport.cancer.gov/doc-detail.asp?pid=1&did= 2007&chid=75&coid=726&mid=
8. Himmelstein DU, Warren E, Thorne D, et al: Illness and injury as contributors to bankruptcy. Health Aff (Millwood) W5:63-73, 2005 (suppl)
9. Arozullah AM, Calhoun EA, Wolf M, et al: The financial burden of cancer: Estimates from a study of insured women with breast cancer. J Support Oncol 2:271-278, 2004
10. Henry J. Kaiser Family Foundation: Toplines: National survey of households affected by cancer. http://www.kff.org/kaiserpolls/7590.cfm
11. Langa KM, Fendrick AM, Chernew ME, et al: Out-of-pocket health-care expenditures among older Americans with cancer. Value Health 7:186-194, 2004 (Pubitemid 38420731)
12. Schrag D, Hanger M: Medical oncologists' views on communicating with patients about chemotherapy costs: A pilot survey. J Clin Oncol 25:233-237, 2007
13. Schrag D: The price tag on progress: Chemotherapy for colorectal cancer. N Engl J Med 351:317-319, 2004
14. Doshi JA: Impact of a prescription copayment increase on lipid lowering medication adherence in veterans. Presented at the 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Baltimore, MD, April 30-May 2, 2008
15. Gibson TB, Mark TL, McGuigan KA, et al: The effects of prescription drug copayments on statin adherence. Am J Manag Care 12:509-517, 2006
16. Schneeweiss S, Patrick AR, Maclure M, et al: Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: A population-based natural experiment. Circulation 115:2128-2135, 2007 (Pubitemid 46659064)
17. Ward E, Halpern M, Schrag N, et al: Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58:9-31, 2008
18. Alexander GC, Casalino LP, Meltzer DO: Patient-physician communication about out-of-pocket costs. JAMA 290:953-958, 2003
19. Alexander GC, Casalino LP, Tseng CW, et al: Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med 19:856-860, 2004
20. Gaskin DJ, Weinfurt KP, Castel LD, et al: An exploration of relative health stock in advanced cancer patients. Med Decis Making 24:614-624, 2004
21. Weinfurt KP: Value of high-cost cancer care: A behavioral science perspective. J Clin Oncol 25:223-227, 2007
22. Matsuyama R, Reddy S, Smith TJ: Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24:3490-3496, 2006
23. Mackillop WJ, Stewart WE, Ginsburg AD, et al: Cancer patients' perceptions of their disease and its treatment. Br J Cancer 58:355-358, 1988
24. The AM, Hak T, Koëter G, et al: Collusion in doctor-patient about imminent death: An ethnographic study. West J Med 174:247-253, 2001
25. Elkin EB, Kim SH, Casper ES, et al: Desire for information and involvement in treatment decisions: Elderly cancer patients' preferences and their physicians' perceptions. J Clin Oncol 25:5275-5280, 2007
26. Lamont EB, Siegler M: Paradoxes in cancer patients' advance care planning. J Palliat Med 3:23-25, 2000
27. Harrington SE, and Smith TJ: The role of chemotherapy at the end of life: "When is enough, enough?" JAMA 299:2667-2678, 2008
28. Stacey D, Samant R, Bennett C: Decision making in oncology: A review of patient decision aids to support patient participation. CA Cancer J Clin 58:293-304, 2008
29. Dranitsaris G, Elia-Pacitti J, Cottrell W: Measuring treatment preferences and willingness to pay for docetaxel in advanced ovarian cancer. Pharmacoeconomics 22:375-387, 2004
30. Aristides M, Chen J, Schulz M, et al: Conjoint analysis of a new chemotherapy: Willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced colorectal cancer. Pharmacoeconomics 20:775-784, 2002
31. Tan Sean P, Chouaid C, Hettler D, et al: Economic implications of using pegfilgrastim rather than conventional G-CSF to prevent neutropenia during small-cell lung cancer chemotherapy. Curr Med Res Opin 25:1455-1460, 2009
32. American Society of Clinical Oncology: Managing the cost of cancer care. http://www.cancer.net/managingcostofcare